Spark Therapeutics, Inc.'s ticker is and the CUSIP is 084652J13. A total of 1 filers reported holding Spark Therapeutics, Inc. in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $23,000 | -30.3% | 600 | 0.0% | 0.01% | -17.6% |
| Q3 2018 | $33,000 | +37.5% | 600 | +100.0% | 0.02% | +21.4% |
| Q2 2018 | $24,000 | +20.0% | 300 | 0.0% | 0.01% | +16.7% |
| Q1 2018 | $20,000 | +33.3% | 300 | 0.0% | 0.01% | +33.3% |
| Q4 2017 | $15,000 | -44.4% | 300 | 0.0% | 0.01% | -50.0% |
| Q3 2017 | $27,000 | +50.0% | 300 | 0.0% | 0.02% | +50.0% |
| Q2 2017 | $18,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 600 | $33,000 | 0.02% |